1. Home
  2. ICCC vs TACT Comparison

ICCC vs TACT Comparison

Compare ICCC & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • TACT
  • Stock Information
  • Founded
  • ICCC 1982
  • TACT 1996
  • Country
  • ICCC United States
  • TACT United States
  • Employees
  • ICCC N/A
  • TACT N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • TACT Computer peripheral equipment
  • Sector
  • ICCC Health Care
  • TACT Technology
  • Exchange
  • ICCC Nasdaq
  • TACT Nasdaq
  • Market Cap
  • ICCC 35.4M
  • TACT 37.5M
  • IPO Year
  • ICCC 1987
  • TACT 1996
  • Fundamental
  • Price
  • ICCC $4.16
  • TACT $3.90
  • Analyst Decision
  • ICCC
  • TACT Strong Buy
  • Analyst Count
  • ICCC 0
  • TACT 1
  • Target Price
  • ICCC N/A
  • TACT $7.50
  • AVG Volume (30 Days)
  • ICCC 6.2K
  • TACT 11.0K
  • Earning Date
  • ICCC 08-08-2024
  • TACT 08-07-2024
  • Dividend Yield
  • ICCC N/A
  • TACT N/A
  • EPS Growth
  • ICCC N/A
  • TACT N/A
  • EPS
  • ICCC N/A
  • TACT 0.06
  • Revenue
  • ICCC $21,282,719.00
  • TACT $61,048,000.00
  • Revenue This Year
  • ICCC N/A
  • TACT N/A
  • Revenue Next Year
  • ICCC N/A
  • TACT $21.64
  • P/E Ratio
  • ICCC N/A
  • TACT $65.00
  • Revenue Growth
  • ICCC 32.89
  • TACT N/A
  • 52 Week Low
  • ICCC $4.05
  • TACT $3.32
  • 52 Week High
  • ICCC $5.75
  • TACT $8.80
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 42.25
  • TACT 54.92
  • Support Level
  • ICCC $4.10
  • TACT $3.76
  • Resistance Level
  • ICCC $4.29
  • TACT $3.98
  • Average True Range (ATR)
  • ICCC 0.11
  • TACT 0.18
  • MACD
  • ICCC -0.00
  • TACT 0.04
  • Stochastic Oscillator
  • ICCC 13.04
  • TACT 81.82

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: